Trademarkia Logo

Canada

C$
formulate & Design
SEARCHED

on 8 Nov 2024

Last Applicant/ Owned by

Formulate Bioscience, Inc.

54 Baskin RoadLexington, MA 02421

US

Serial Number

2106229 filed on 12th May 2021

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

formulate & Design

Trademark usage description

pharmaceutical preparations; human endocannabinoid system-based therapies; therapeutic agents for binding and activating encannabinoid receptors phar Read More

Vienna Information


5 . 3 . 20

Other branches with leaves, with or without fruitAutres rameaux avec feuilles, avec ou sans fruits

26 . 5 . 1

One polygonUn polygone

26 . 5 . 8

Polygons with one or more truncated or rounded anglesPolygones avec un ou plusieurs angles tronqués ou arrondis

26 . 5 . 15

Polygons containing representations of animals or parts of animals' bodies or plantsPolygones contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 5 . 24

Polygons with dark surfaces or parts of surfacesPolygones avec surface ou partie de la surface foncée

26 . 5 . 26

Polygons with cutout areasPolygones avec des zones découpées

Classification Information


Class [001]
Chemicals and adhesives


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [005]
Pharmaceutical preparations; human endocannabinoid system-based therapies; therapeutic agents for binding and activating encannabinoid receptors


Classification kind code

11

Class [042]
Pharmaceutical research and development services; research and development services in the field of endocannabinoid systems; providing medical and scientific research information in the field of endocannabinoid systems and endocannabinoid system-based therapies


Classification kind code

11

Mark Details


Serial Number

2106229

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 15
on 13th Nov 2024
Correspondence Created
Submitted for opposition 22
on 8th Nov 2024
Search Recorded
Submitted for opposition 20
on 8th Nov 2024
Examiner's First Report
Submitted for opposition 67
on 7th Oct 2022
Agent Name Changed
Submitted for opposition 287
on 4th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 12th May 2021
Filed
Submitted for opposition 1
on 12th May 2021
Created
Submitted for opposition 31
on 12th May 2021
Formalized